Cynthia Yee
Partner @ Vensana Capital
San Francisco, United States
Cynthia Yee is a Partner at Vensana Capital. Prior to joining Vensana, Cynthia served as a Principal at Windham Venture Partners where she led the firm's investments in Cartiva Medical, ClarVista Medical, Personal Genome Diagnostics, and Neuspera Medical and helped open the firm's San Francisco office. Previously, Cynthia served asDirector of Business Development & Strategic Marketing at Epix Therapeutics (fka Advanced Cardiac Therapeutics) and medtech incubator D3 Development Corp, which spun-out three companies, including Spirox. Cynthia was also an investor on the Healthcare team at New Enterprise Associates (NEA) and focused on investments in medical device, biopharmaceutical and healthcare services companies. At NEA, Cynthia helped allocate over $250M in capital to healthcare companies in the peripheral and cardiovascular, spine, diabetes, urology and women’s health industries. Cynthia began her career in equity research, covering medical devices at Piper Jaffray and biopharma at Pacific Growth Equities.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 75%
Last updated:
For AI agents: llms.txt
Industries Cynthia Yee invests in
Stages Cynthia Yee invests in
Countries Cynthia Yee invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (75%)
- Medical 2 (50%)
- Medical Device 2 (50%)
- Health Diagnostics 2 (50%)
- Wellness 1 (25%)
Stage
- Series B 3 (75%)
- Series A 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Evident Vascular offers an advanced IVUS platform that leverages Artificial Intelligence to deliver superior Vascular. | Series B / Mar 25, 2025 | ||
| Evident Vascular offers an advanced IVUS platform that leverages Artificial Intelligence to deliver superior Vascular. | $35M / Series A / Oct 17, 2023 | ||
| Spyglass Ophthalmics develops ophthalmic devices intended to improve vision and eye care of patients. Spyglass' devices address unmet needs in cataract, lens replacement, surgery, and other chronic ophthalmic diseases, enabling patients to get quality eye treatment at an affordable cost. | $27.5M / Series B / Jan 07, 2021 | ||
| ClarVista Medical is a developer of innovative products to treat challenging ophthalmic conditions. In 2012 and in conjunction with series A financing, ClarVista was spun out from Prospex Medical, a medical device incubator, to pursue the development of the HARMONI™ IOL. Between 2012 and 2014, the company developed the first generation HARMONI™system, conducted thorough first-in-human clinical study and developed a broad portfolio of intellectual property. In 2015 the company closed on a series B financing of $14M which will be used to develop the second generation HAROMONI™ system, conduct a larger feasibility clinical trial and obtain key regulatory approvals including CE mark and US IDE. | $14.5M / Series B / May 20, 2015 |
Co-Investors
About Vensana Capital
Vensana Capital is a venture capital investment firm that focuses on healthcare with breakthrough innovations in medical technology.
Vensana Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Aaron Smith
Advisor
|
|||
|
Cynthia Yee
Partner
|
|||
Greg Banker
Vice President
|
|||
Justin Klein
Co-Founder & Managing Partner
|
|||
Kirk Nielsen
Co-Founder & Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Cynthia Yee invest in?
Cynthia Yee invests primarily in Health Care, Medical and Medical Device startups, most often at Series B and Series A stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Cynthia Yee?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Cynthia Yee last invest?
The most recent investment recorded for Cynthia Yee closed in Mar 2025. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
